Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?

Caused by SARS-CoV-2, the ongoing COVID-19 pandemic has led to over 121.2 million cases and over 2.6 million deaths worldwide. An interesting new study examines the potential antiviral activity of compounds present in the plant Artemisia annua L.

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants

An overview on medicinal plants used for combating coronavirus: Current potentials and challenges - ScienceDirect

Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights - ScienceDirect

Frontiers A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment

Terpenes, meroterpenoids, and artemisinin and SARS-CoV-2 - ScienceDirect

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis

IJMS, Free Full-Text

Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 3 (2020)

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect